Recent changes
GovPing tracks 152 sources across this role, spanning Guidance, Enforcement, Rule, FAQ, Notice, and Consultation instruments. Of 2,836 total GovPing sources, 573 changes were logged in the last 7 days.
ANSM initiated multiple urgent recalls including six lots of MaaT013 fecal microbiota product over a donor screening flaw and lot withdrawals of Olympus Gyrus ACMI Everest surgical forceps and FH Ortho hip prosthesis femoral heads. Boston Scientific published updated safety information for Accolade family pacemakers. The California Board of Pharmacy revoked 40+ pharmacy licenses in Q1 2026, while two Alabama physicians—including Dr. Brett Tyler Wahlgren and Evann Max Herrell—voluntarily surrendered their medical licenses.
No changes tracked yet for Pharma & Life Sciences.
Sources are being set up. Changes will appear here as they're detected.
Get daily alerts for pharma & life sciences
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
571 changes in last 7 days
Latest high priority updates
152 official sources tracked
Frequently asked questions
What does this feed cover?
FDA warning letters, novel drug approvals, drug shortage notices, ICH guideline updates, USP notices, EMA news, DEA scheduling decisions, and TGA/WHO standards.
Who is this for?
Regulatory affairs professionals, pharmacovigilance teams, and medical affairs groups at pharma companies and CROs who need to track FDA and EMA actions.
How often is this updated?
GovPing checks source pages multiple times daily. FDA warning letters and drug approvals typically appear within hours of publication.
Does this cover EMA and international regulators?
Yes. We monitor the EMA, ICH, WHO, TGA (Australia), and other international health authorities alongside FDA.
How is this different from AgencyIQ?
AgencyIQ is a full FDA intelligence platform. GovPing is a free feed of the FDA, EMA, and ICH source pages where warning letters, approvals, drug shortages, and guidance are first published - AI-summarized with attention-level ratings on every change.
Is GovPing free?
Yes. GovPing is free, and always will be. We believe government regulatory data should be accessible to everyone. For custom monitoring of pages we don't cover yet, Changeflow starts at $99/mo.
Need to monitor something else?
GovPing covers the common sources. For niche pages specific to your team, add custom URL monitoring with Changeflow.
Get Pharma & Life Sciences alerts
Daily digest of pharma & life sciences regulatory changes. AI-summarized, no noise.
Free. Unsubscribe anytime.